For example, it has been shown that resveratrol inhibits PDE1, PDE3, and PDE4 and thereby mediates the increase of cAMP levels and AMPK activation via the Epac and CamKKB pathway, leading to metabolic benefits such as the prevention of diet-induced obesity and diabetes. The gene discussed is PRKAB1; the disease is diabetes mellitus.